ArticlePharmacology research & perspectives2019

A novel soluble guanylate cyclase activator with reduced risk of hypotension by short-acting vasodilation.

Toshihiro Sawabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.